Clinical Trial

Defining Recurrent Disease with Axuminâ„¢

Study Description

Defining Recurrent Disease With Axuminâ„¢

This project seeks to use advanced imaging (specifically, positron emission tomography/computed tomography [PET/CT]) to detect, locate, and characterize recurrent disease in the setting of patients with prostate cancer.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Casodex, Axumin

Patients will receive hormone therapy if Axumin positive area appears.

Radiation - Salvage Radiation, Axumin

Patients will receive salvage radiation therapy if Axumin positive area appears.

Additional Information

Official Study Title

Diagnosing and Monitoring Recurrent Disease in Prostate Cancer Patients Using a Positron Emission Tomography Radiotracer (Axuminâ„¢)

Clinical Trial ID

NCT03996993

ParticipAid ID

dwp68e